安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Treatment of Stage IV (Metastatic) Breast Cancer
Advanced cancer that progresses during treatment Treatment for advanced breast cancer can often shrink the cancer or slow its growth (sometimes for many years), but after a time, it tends to stop working Further treatment options at this point depend on several factors, including previous treatments, where the cancer is located, a woman's
- ASCO 2025 Metastatic Breast Cancer Updates | Breast Cancer Research . . .
Investigators presented several potentially practice-changing treatment advances for these patients At the annual meeting of the American Society of Clinical Oncology (ASCO), there was a keen focus on metastatic breast cancer (MBC) Thanks to research, more patients are living with MBC than ever before—but it remains incurable
- Treatments for Metastatic Breast Cancer | Susan G. Komen®
Metastatic breast cancer is the most advanced stage of breast cancer It’s not a specific type of breast cancer Although the exact treatment for metastatic breast cancer varies from person to person, guidelines help make sure high-quality care is given These guidelines are based on the latest research and agreement among experts
- Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO . . .
The purpose of this guideline is to provide expert guidance on the systemic treatment of metastatic breast cancer (MBC) to clinicians, public health leaders, patients, and policymakers in resource-constrained settings If a patient's HER2-positive advanced breast cancer has progressed during or after second-line or greater HER2-targeted
- ASCO 2025: New Standards Reshape Care in mBC - Medscape
Heather McArthur, MD, describes how the 2025 ASCO Annual Meeting brought exciting advances in the metastatic breast cancer space In PD-L1-positive triple-negative breast cancer, sacituzumab
- Metastatic Breast Cancer: Current and Emerging Treatments
Metastatic Breast Cancer: Current and Emerging Treatments While many treatment options are available, metastatic breast cancer remains a deadly disease with a relatively poor prognosis et al Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b 4 trial Nat Med 2024;30:3717-3727
- Overall Survival with Inavolisib in PIK3CA-Mutated Advanced Breast Cancer
Dr Jhaveri can be contacted at [email protected] or at the Breast and Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 E 66th St , 8th Flr
- Current Treatment Approaches in HER2+ Metastatic Breast Cancer
The current treatment landscape for HER2-positive metastatic breast cancer has evolved significantly, with recent updates further refining patient care strategies Historically, the CLEOPATRA regimen—trastuzumab, pertuzumab, and docetaxel—has been the preferred first-line therapy, offering substantial progression-free and overall survival
|
|
|